At Investor Conferences

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2022 650x100

News > All

Total search results: 1272 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Navis Capital Partners. (8/9/22). "Press Release: Navis Capital Partners Announces the Sale of 100% of B Medical Systems to Azenta, Inc". Singapore. 2022-08-09
Azenta, Inc.. (8/8/22). "Press Release: Azenta Announces Agreement to Acquire B Medical Systems". Chelmsford, MA. 2022-08-08
F2G Ltd.. (8/4/22). "Press Release: F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim". Manchester. 2022-08-04
Sosei Group Corporation (d/b/a Sosei Heptares). (8/2/22). "Press Release: Sosei Heptares and AbbVie Enter New Multi-target Collaboration to Discover, Develop and Commercialize Novel Medicines Targeting Neurological Diseases". Tokyo & Cambridge. 2022-08-02
Eppendorf SE. (8/1/22). "Press Release: Eppendorf Opens New Site in Singapore". Singapore & Hamburg. 2022-08-01
Manifold Biotechnologies, Inc.. (7/14/22). "Press Release: Manifold Bio Raises $40 Million Series A to Expand In Vivo Biologics Design Platform". Boston, MA. 2022-07-14
BeiGene, Ltd.. (7/13/22). "Press Release: BeiGene Appoints Chan Lee as General Counsel". Cambridge, MA, Basel & Beijing. 2022-07-13
Heidelberg Pharma AG. (7/13/22). "Press Release: Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate (ad hoc)". Ladenburg. 2022-07-13
Epic Bio (Epicrispr Biotechnologies, Inc.). (7/12/22). "Press Release: Epic Bio, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine with Epigenetic Engineering". South San Francisco, CA. 2022-07-12
Phytolon Ltd.. (7/7/22). "Press Release: Biotech Food Colorant Startup Phytolon Closes $14.5 Million Series A Funding Round, Led by DSM Venturing". Yokneam Illit. 2022-07-07
BeiGene, Ltd.. (7/6/22). "Press Release: BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies". Cambride, MA, Basel & Beijing. 2022-07-06
Mogrify Ltd.. (7/5/22). "Press Release: Mogrify and Astellas Announce Collaboration to Conduct Research on in vivo Regenerative Medicine Approaches to Address Sensorineural Hearing Loss". Cambridge & Tokyo. 2022-07-05
Urovant Sciences. (7/5/22). "Press Release: Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland". Basel & 2022-07-05
BIO Deutschland e. V.. (6/29/22). "Press Release: President of German Biotechnology Industry Association Elected Chairman of International Umbrella Organization". Berlin. 2022-06-29
ReCode Therapeutics. (6/29/22). "Press Release: ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M". Menlo Park, CA & Dallas, TX. 2022-06-29
Molzym GmbH & Co. KG. (6/29/22). "Press Release: Molzym Announces Double-Digit Million EUR Capital Increase". Bremen. 2022-06-29
F-Star Therapeutics, Inc.. (6/23/22). "Press Release: invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs". London. 2022-06-23
Hong Kong Science and Technology Parks (HKSTP). (6/17/22). "Press Release: HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to Fast-track R&D in Infectious Diseases and Immunology". Hong Kong. 2022-06-17
Upstream Bio (US). (6/2/22). "Press Release: Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases". Waltham, MA. 2022-06-02
Transition Bio, Inc.. (6/2/22). "Press Release: Transition Bio Closes $50 Million Series A Financing to Accelerate Biomolecular Condensate Drug Discovery". Cambridge, MA & Cambridge. 2022-06-02
Watchmaker Genomics, Inc.. (6/2/22). "Press Release: Watchmaker Genomics Raises $40M Series A Financing to Accelerate Growth and Expand Clinical Sequencing Product Offerings". Boulder, CO. 2022-06-02
Transine Therapeutics Ltd.. (5/31/22). "Press Release: Transine Therapeutics Announces Final Closing of Its Seed Round at £13.7m to Accelerate Its Platform and Portfolio Development". Cambridge. 2022-05-31
Eurofins Scientific SE. (5/31/22). "Press Release: Eurofins Enhances Its Clinical and BioPharma Service Offering in Japan with Immune Repertoire Analysis Technology Through the Acquisition of Repertoire Genesis Inc.". Luxembourg. 2022-05-31
uMotif Ltd.. (5/25/22). "Press Release: uMotif – the Patient-first Data Capture and Decentralized Clinical Trials Platform – Announces $25.5m of New Investment from a Fund Managed by Athyrium Capital Management". London & New York, NY. 2022-05-25
BeiGene, Ltd.. (5/17/22). "Press Release: BeiGene Strengthens European Presence With the Opening of Regional Office in Basel, Switzerland". Cambridge, MA, Basel & Beijing. 2022-05-17
Sosei Group Corporation (d/b/a Sosei Heptares). (5/17/22). "Press Release: Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery". Tokyo, Cambridge & New York, NY. 2022-05-17
F2G Ltd.. (5/16/22). "Press Release: Shionogi Co., Ltd. and F2G Enter Strategic Collaboration to Develop and Commercialize the New Antifungal Agent Olorofim in Europe and Asia". Osaka & Manchester. 2022-05-16
Enzymaster Deutschland GmbH. (5/12/22). "Press Release: Enzymaster Completes Round-C Financing to Accelerate Innovation, Increase Capabilities, and Expand Capacity". Düsseldorf. 2022-05-12
Domain Therapeutics S.A.. (5/12/22). "Press Release: Domain Therapeutics Raises $42m Series A Financing to Accelerate Clinical Development of Its Best-in-Class and First-in-Class Immuno-oncology Programs". Strasbourg & Montréal, ON. 2022-05-12
Proteona Pte. Ltd.. (5/11/22). "Press Release: Proteona Opens New Laboratory in Singapore. New Facility Will also Serve as Regional Headquarters for Singleron in Asia". Singapore. 2022-05-11
InxMed Co., Ltd.. (5/9/22). "Press Release: InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers". Nanjing. 2022-05-09
Hovione. (5/9/22). "Press Release: Hovione and Jixing Announce an Exclusive Global License Agreement for Ophthalmology Program". Lisbon & Shanghai. 2022-05-09
Coriolis Pharma Research GmbH. (5/4/22). "Press Release: Coriolis Pharma Appoints Silvia Steyrer-Gruber as New Chief Executive Officer". Martinsried. 2022-05-04
Bone Therapeutics S.A.. (4/29/22). "Press Release: Bone Therapeutics Announces 2021 Full Year Results". Mont-Saint-Guibert. 2022-04-29
Merck KGaA. (4/29/22). "Press Release: Merck Invests Approximately € 100 Million to Accelerate Single-Use Manufacturing in China". Darmstadt. 2022-04-29
Moderna, Inc.. (4/27/22). "Press Release: Arpa Garay Joins Moderna as Chief Commercial Officer". Cambridge, MA. 2022-04-27
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/21/22). "Press Release: SHS Sells Shares in Bochum-based Phenox GmbH, a Leading Manufacturer of Instruments and Implants for the Treatment of Stroke". Tübingen. 2022-04-21
Tessera Therapeutics. (4/19/22). "Press Release: Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING Platform". Somerville, MA. 2022-04-19
Be Biopharma, Inc.. (4/14/22). "Press Release: Be Bio Closes $130 Million Financing to Pioneer Engineered B Cells, a New Class of Cellular Medicines". Cambridge, MA. 2022-04-14
Terumo Blood and Cell Technologies. (4/13/22). "Press Release: CEO Antoinette Gawin Will Serve as Group Managing Executive Officer in Terumo Corporation’s New Executive Officers’ Management System". Lakewood, CO. 2022-04-13
Bayer AG. (4/13/22). "Press Release: Bayer Receives Approval for Precision Oncology Treatment Vitrakvi in China [Not intended for U.S. and UK Media]". Berlin. 2022-04-13
Bone Therapeutics S.A.. (4/12/22). "Press Release: Bone Therapeutics Secures EUR 5 Million Financing [Not for US, AU, CA, et al.]". Mont-Saint-Guibert. 2022-04-12
List Biotherapeutics, Inc.. (4/12/22). "Press Release: List Bio Raises $48.4 Million Series A for Global Scale-Up". Seoul. 2022-04-12
Ansa Biotechnologies, Inc.. (4/11/22). "Press Release: Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing to Power the Next Era of DNA-Enabled Industries". Emeryville, CA. 2022-04-11
TreeFrog Therapeutics S.A.S.. (4/8/22). "Press Release: TreeFrog Therapeutics Opens Technological Hub in Kobe, Japan, to Drive Partnerships Opportunities in the Field of iPSC-derived Cell Therapies". Kobe. 2022-04-08
H. Lundbeck A/S. (4/8/22). "Press Release: Joerg Hornstein to Join Lundbeck as Chief Financial Officer and Head of Corporate Functions". Valby. 2022-04-08
ReViral Ltd.. (4/7/22). "Press Release: Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates". New York, NY, London & Research Triangle Park, NC. 2022-04-07
LimFlow S.A.. (4/6/22). "Press Release: LimFlow Raises $40 Million (€36 Million) in Series D Financing". Paris. 2022-04-06
DNA Script. (4/5/22). "Press Release: DNA Script Partners with Asia-Pacific Distributors as Part of Global Expansion to Meet Demand for Same-day Enzymatic DNA Synthesis". South San Francisco, CA & Paris. 2022-04-05
Novartis AG. (4/4/22). "Press Release (Ad hoc): Novartis Announces New Organizational Structure to Accelerate Growth, Strengthen Pipeline and Increase Productivity". Basel. 2022-04-04
Oxford Gene Technology Ltd.. (4/4/22). "Press Release: OGT Welcomes Adrian Smith as CEO". Oxford. 2022-04-04
Labster ApS. (4/4/22). "Press Release: Labster Secures $47M in New Funding Tranche to Expand Global Opportunities for Virtual Science Laboratory Simulations". Copenhagen & Boston, MA. 2022-04-04
VectivBio Holding AG. (3/30/22). "Press Release: VectivBio Announces Japan License Deal and Loan Facility Agreement, Providing up to $117 Million to Fuel the Company Through Key Catalysts". Basel. 2022-03-30
Neuron23 Inc.. (3/30/22). "Press Release: Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease". South San Francisco, CA. 2022-03-30
Bone Therapeutics S.A.. (3/29/22). "Press Release: Bone Therapeutics to Strategically Focus on Lead Cell Therapy Product ALLOB". Mont-Saint-Guibert. 2022-03-29
Integra Thepeutics S.L.. (3/29/22). "Press Release: Integra Therapeutics Closes a New Investment of €1.5 Million with the Addition of Columbus Venture Partners to Seed Round". Barcelona. 2022-03-29
Novo Holdings A/S. (3/29/22). "Press Release: Qure.ai Raises $40 Million from Healthcare Investors Novo Holdings and HealthQuad". Copenhagen, Mumbai & New York, NY. 2022-03-29
InnoRNA Biotechnology Co., Ltd.. (3/28/22). "Press Release: InnoRNA Raises USD 120 Million in Series B Funding". Shenzhen. 2022-03-28
LifeMine Therapeutics Inc.. (3/23/22). "Press Release: LifeMine Therapeutics Announces $175 Million Series C Financing". Cambridge, MA. 2022-03-23
Nucleai MD. (3/22/22). "Press Release: Nucleai Closes $33 Million Series B Financing to Advance Spatial Biology Platform for Drug Research, Development and Diagnostics". Tel Aviv. 2022-03-22
ITM Isotope Technologies Munich SE. (3/22/22). "Press Release: ITM Receives EUR 33 Million Equity Investment to Advance Precision Oncology Pipeline of Targeted Radiopharmaceuticals". Garching. 2022-03-22
Bavarian Nordic A/S. (3/21/22). "Press Release: Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets 2022-03-21
Bruker Corporation. (3/16/22). "Press Release: Bruker Appoints Philip Ma to Its Board of Directors". Billerica, MA. 2022-03-16
Ayoxxa Biosystems GmbH. (3/14/22). "Press Release: Ayoxxa Receives Fresh Capital for Commercial Growth in Europe, US and Asia Led by Prosnav Capital". Cologne. 2022-03-14
MediLink Therapeutics (Suzhou) Co., Ltd.. (3/14/22). "Press Release: MediLink Therapeutics Closes US$70 Million Series B Financing". Suzhou. 2022-03-14
Vaximm AG. (3/8/22). "Press Release: NEC OncoImmunity Acquires Vaximm’s Neoantigen Vaccine Development Assets". Oslo, Tokyo, Basel & Mannheim. 2022-03-08
Enzymicals AG. (3/8/22). "Press Release: Enzymicals AG Board of Supervisors Appoints New Management with Dr. Erik de Vries as CEO". Greifswald. 2022-03-08
Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov". 2022-03-07
Singleron Biotechnologies. (3/7/22). "Press Release: Singleron Acquires Proteona". Nanjing, Suzhou, Cologne & Singapore. 2022-03-07
InxMed Co., Ltd.. (3/4/22). "Press Release: InxMed Raised $50 Million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers". Nanjing. 2022-03-04
EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences". 2022-03-01
Heidelberg Pharma AG. (2/28/22). "Press Release: Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment". Ladenburg. 2022-02-28
Yposkesi. (2/28/22). "Press Release: Yposkesi, an SK pharmteco Company, Appoints US-based Executive Director for Business Development". Corbeil-Essonnes. 2022-02-28
Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA. 2022-02-24
ITM Isotope Technologies Munich SE. (2/16/22). "Press Release: ITM Receives Equity Investment of EUR 25 Million from Strategic Partner Grand Pharma". Garching & Hong Kong. 2022-02-16
ChinaBio LLC. (2/15/22). "Press Release: ChinaBio Partnering Forum Acquired by EBD Group/Informa". Carlsbad, CA & Shanghai. 2022-02-15
Newton Biocapital. (2/15/22). "Press Release: Newton Biocapital Launches a New Fund with Initial Capital Commitments of EUR 50 Million and Target Size of EUR 150 Million". Brussels. 2022-02-15
Celeris Therapeutics GmbH. (2/10/22). "Press Release: CelerisTx Announces $4.4m Financing to Advance Pipeline of Novel Proximity Inducing Compound". Menlo Park, CA. 2022-02-10
Ventus Therapeutics, Inc.. (2/9/22). "Press Release: Ventus Therapeutics Closes $140 Million Series C Financing". Waltham, MA & Montréal, QC. 2022-02-09
Haya Therapeutics S.A.. (2/9/22). "Press Release: Haya Therapeutics Establishes U.S. Location. Haya Closes US$5M Seed Extension". Lausanne & San Diego, CA. 2022-02-09
AMR Action Fund. (2/7/22). "Press Release: AMR Action Fund Opens European Office". Boston, MA. 2022-02-07
iOmx Therapeutics AG. (2/3/22). "Press Release: iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development". Martinsried. 2022-02-03
CellCentric Ltd.. (1/26/22). "Press Release: CellCentric Secures Investment from the American Cancer Society’s Impact Venture Capital Fund". Cambridge. 2022-01-26
Metagenomi Inc.. (1/25/22). "Press Release: Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform". Emeryville, CA. 2022-01-25
Leyden Laboratories B.V.. (1/25/22). "Press Release: Leyden Labs Raises $200M in 2021 for a New Approach to Combat Viruses". Amsterdam & Boston, MA. 2022-01-25
Shimadzu Corporation. (1/24/22). "Press Release: MALDI-8030 – Shimadzu Adds further Versatility to Existing Class-leading Line Up of MALDI-TOF Mass Spectrometers". 2022-01-24
Argenx SE. (1/20/22). "Press Release: Argenx Announces Vyvgart Approval in Japan for the Treatment of Generalized Myasthenia Gravis". Breda. 2022-01-20
Centogene N.V.. (1/20/22). "Press Release: Centogene Joins Forces with Insilico Medicine for Niemann-Pick Disease Type C (NPC) Target Discovery, Applying Artificial Intelligence (AI) to Accelerate Orphan Drug Development". Cambridge, MA, Rostock & Berlin 2022-01-20
Psyros Diagnostics Ltd.. (1/20/22). "Press Release: Psyros Diagnostics Ltd Acquired by Prolight Diagnostics AB". 2022-01-20
Altos Labs. (1/19/22). "Press Release: Altos Labs Launches with the Goal to Transform Medicine through Cellular Rejuvenation Programming". San Francisco, CA. 2022-01-19
Pneumagen Ltd.. (1/19/22). "Press Release: Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)". St Andrew 2022-01-19
ADC Therapeutics S.A.. (1/18/22). "Press Release: ADC Therapeutics Announces Exclusive License with Mitsubishi Tanabe Pharma Corporation to Develop and Commercialize Zynlonta(loncastuximab tesirine-lpyl) in Japan". Lausanne. 2022-01-18
Neurimmune AG. (1/17/22). "Press Release: Neurimmune Expands Drug Discovery Collaboration with Ono Pharmaceutical in the Field of Neurodegenerative Diseases". Zürich. 2022-01-17
Santhera Pharmaceuticals Holding AG. (1/4/22). "Press Release: Santhera Enters into Exclusive License Agreement with Sperogenix for Vamorolone in Rare Diseases in the Greater China Region". Pratteln. 2022-01-04
ITM Isotope Technologies Munich SE. (12/27/21). "Press Release: ITM and Grand Pharma Enter into a Commercialization Agreement for Targeted Radiopharmaceuticals in the Greater China Area". Garching & Hong Kong. 2021-12-27
Novartis AG. (12/20/21). "Press Release: Novartis Strengthens Immunotherapy Pipeline with Option, Collaboration and License Agreement with BeiGene for TIGIT inhibitor Ociperlimab". Basel. 2021-12-20
Future Meat Technologies. (12/20/21). "Press Release: Future Meat Technologies Raises $347 Million Series B Markting the Largest Investment Ever in Cultivated Meat". Rehovot. 2021-12-20
Glycomine, Inc.. (12/17/21). "Press Release: Glycomine Closes $68 Million Series B to Advance into Clinical Trials a Novel Treatment for PMM2-CDG, a Rare Glycosylation Disease". San Carlos, CA. 2021-12-17
Genfit S.A.. (12/17/21). "Press Release: Ipsen and Genfit Enter into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-term Global Partnership". Paris. 2021-12-17
Brainomix Ltd.. (12/16/21). "Press Release: Brainomix Closes £16M ($21.2M) Financing Round to Expand Its Proven AI-enabled Platform Beyond Stroke". Oxford. 2021-12-16
1 2 3 4 5 6 7 8 9 10 11 12 13  next pagenext page



Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group BioPharm Amercia 2022 Boston 650x300px

» top